Goudy Park Capital
Long/short equity, long-term horizon

Liberator Medical: Long-Term Value

At one point yesterday, Liberator Medical (NYSEMKT:LBMH) dropped over 33% on no news. It closed at 4.68, and throughout it all, we have continued to hold onto our position in the company, which we have followed closely since 2010. We do not see any changes in the business model that make us concerned, and instead, only see continued improvement. Our thesis from the prior article before is still intact, and we urge readers to take a closer look at the business and make an educated decision for themselves.

When we last mentioned LBMH (article here), the stock was trading at $2/share and valued at 4x EV/EBITDA. In the last few months, LBMH became listed on the...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details